FDA inspection
Gadal Laboratories Inc.: FDA inspection ending Feb 17, 2023
FDA inspection 1197938 · Official Action Indicated (OAI) · Miami, FL
Key facts
| Inspection ID | 1197938 |
|---|---|
| Firm | Gadal Laboratories Inc. |
| FEI number | 3008611487 |
| Address | 12178 Sw 128th St |
| City | Miami |
| State | FL |
| ZIP | 33186 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Feb 17, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 655929 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data